Article

Homologous Recombination Deficiency as a Novel Therapeutic Target in Various Solid Tumors

2021-05-04

Abstract excerpt

<title>Abstract</title> <p>Background: Homologous recombination deficiency (HRD) is related to tumorigenesis. Currently, the possibility of HRD as a prognostic biomarker to immune check point inhibitors is unknown. <h4>Methods:</h4> The status of homologous recombination deficiency (HRD) was assessed with the next-generation sequencing (NGS) TruSight<sup>TM </sup>Oncology 500 assay in 501 patients with advanced s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 693a9f9d-b3b1-5485-a4ed-43ac0288cab3
DOI: 10.21203/rs.3.rs-453816/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Homologous Recombination Deficiency as a Novel Therapeutic Target in Various Solid TumorsDOI 10.21203/rs.3.rs-453816/v1Read

Multiomics analysis of homologous recombination deficiency across cancer types.Semantic proximity Read

Somatic mutations in homologous recombination pathway predict favorable prognosis after immunotherapy across multiple cancer typesSemantic proximity Read

Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision OncologySemantic proximity Read

Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic ImplicationsSemantic proximity Read

Prevalence of Homologous Recombination–Related Gene Mutations Across Multiple Cancer TypesSemantic proximity Read

Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.Semantic proximity Read

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy durationSemantic proximity Read

Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis and TreatmentSemantic proximity Read

The utility of homologous recombination deficiency biomarkers across cancer typesSemantic proximity Read

Pan-cancer analysis of tumor mutational burden and homologous recombination DNA damage repair by targeted next-generation sequencingSemantic proximity Read

Homologous Recombination Deficiency: Concepts, Definitions, and AssaysSemantic proximity Read

The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancersSemantic proximity Read